According to Spring 2016 Prindex study made by Ipsos Comcon research group, Ingavirin®, medicine for colds developed by PJSC Valenta Pharm, has again taken the top position among medicines the most often prescribed by therapists in 14 large cities of Russia, including Moscow, St.-Petersburg, Ekaterinburg, Novosibirsk, Nizhny Novgorod, etc.1
Immunology and virology are key therapeutic areas for Valenta. The medicine for colds, according to the abovementioned study, was recognized by therapists to have the highest potential of all products included in Valenta’s Cough&Cold portfolio. The Company aspires to bring a significant contribution to combat flu and ARVI to improve the quality of medical aid provided to a wide range of patients of different age groups. Thus, in late 2015, the Company marketed an antiviral medicine in a new dosage for children over 7.
- 1 Results of PrIndex TM “Monitoring of Medicine Prescriptions” study made in April 2016 were presented by OOO Ipsos Comcon at the request of PJSC Valenta Pharm. The period of study: spring 2015 – spring 2016 (selection of medicines covered by the study: according to Table 1 of Prindex TM “Monitoring of Medicine Prescriptions” study, April 2016); covered cities: Moscow, St.-Petersburg, Ekaterinburg, Novosibirsk, Nizhny Novgorod, Samara, Rostov-on-Don, Voronezh, Kazan, Ufa, Omsk, Perm, Chelyabinsk, Volgograd.